FDA Inspection 1068142 — Intermountain Health Care IRB
The FDA completed an inspection of Intermountain Health Care IRB on Sep 20, 2018 in Salt Lake City, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 20, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Salt Lake City, UT (United States)
Additional Details
IRB